| Literature DB >> 29026920 |
Tillmann Rusch1, Jagadeesh Bayry2, Jens Werner1,3, Ivan Shevchenko4, Alexandr V Bazhin5,6.
Abstract
The progress in melanoma immunotherapy highlights the importance of immunotherapy for cancer treatment. Although the concept of immunotherapy emerged in the beginning of the twentieth century, the end of the century signaled the start of modern immunotherapy, which has recently allowed a staggering progress in the field of cancer immunotherapy. Currently, there is a wide variety of immunotherapeutic approaches and critical improvements are continually being made. Among different immunotherapeutic strategies, therapies based on the blockade of immune checkpoint molecules have shown unparalleled efficacy in late-stage cancer patients. Pre-clinical research using ex vivo and in vivo approaches demonstrates the promise of numerous novel strategies for the immunotherapy of cancer.Entities:
Keywords: Adjuvants; Adoptive cell transfer; Cancer vaccine; Checkpoint inhibitors; Cytokines; Immune editing; Immunotherapy; Monoclonal antibody
Mesh:
Substances:
Year: 2017 PMID: 29026920 DOI: 10.1007/s00005-017-0491-5
Source DB: PubMed Journal: Arch Immunol Ther Exp (Warsz) ISSN: 0004-069X Impact factor: 4.291